Search
for
Sort by
Research 61–90 of 501
- A randomized, placebo- and active-controlled, parallel-group, multicenter, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis
- Anthelminthic drugs
- Severe cutaneous adverse reactions to drugs
- Dermatoses of pregnancy
- COVID-19 and Sex Differences
- The pharmacology of methotrexate
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Isotretinoin treatment of acne and related disorders: An update
- The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Tinea Capitis: An Overview with Emphasis on Management
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Alopecia Areata Update
- Treatment of Alopecia Areata With Tofacitinib
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Physiological and pharmacological features of the non-saponin components in Korean Red Ginseng
- Red ginseng monograph
- Telogen effluvium
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Interventions for nail psoriasis
- Factors Associated with Severity of Alopecia Areata
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Graft-versus-host disease